Obesity is associated with IL-6 gene polymorphisms rs1800795 and rs1800796 but not SOCS3 rs4969170 G Koc, T Doran, MM Uygur, D Kirac Molecular Biology Reports 50 (3), 2041-2048, 2023 | 8 | 2023 |
Nasal spray use technique among patients attending the out-patient department of a tertiary Care Hospital, Gandaki Province, Nepal B Kc, GM Khan, N Shrestha Integrated Pharmacy Research and Practice, 155-160, 2020 | 5 | 2020 |
COX-1, COX-2 and CYP2C19 variations may be related to cardiovascular events due to acetylsalicylic acid resistance D Kirac, AE Yaman, T Doran, M Mihmanli, EC Keles Molecular Biology Reports, 1-8, 2022 | 3 | 2022 |
CD4+ and CD25+ T‐cell response to short‐time interferon‐beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients H Gezmis, T Doran, F Mayda Domac, D Yucel, R Karaci, D Kirac International Journal of Clinical Practice 75 (7), e14238, 2021 | 3 | 2021 |
ε2, ε3, and ε4 variants of ApoE; rs2228570 (VDR), rs4588 and rs7041 (VDBP) polymorphisms in patients with multiple sclerosis: A case–control study in … H Gezmis, F Mayda Domac, B Ormeci, H Uyanik, T Doran, EC Keles, ... International Journal of Clinical Practice 75 (11), e14801, 2021 | 2 | 2021 |
Frequency of myelin oligodendrocyte glycoprotein antibodies in pediatric onset multiple sclerosis I Solmaz, T Doran, M Yousefi, B Konuskan, I Oncel, A Vural, B Anlar Multiple Sclerosis and Related Disorders 68, 104097, 2022 | 1 | 2022 |
Myelin oligodendrocyte glycoprotein antibodies in genetic leukodystrophies NG Eroglu-Ertugrul, M Yousefi, F Pekgül, T Doran, C Günbey, M Topcu, ... Journal of Neuroimmunology 369, 577916, 2022 | 1 | 2022 |
Recurrent coronary artery Disease due to Acetylsalicylic Acid Resistance May be related to COX-1 and COX-2 mutations D Kıraç, E Bayram, T Doran, EÇ Keleş Med J Bakirkoy 18 (1), 46-51, 2022 | 1 | 2022 |
CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders O Albayrak, E Tiryaki, N Akkaya, AB Kizilirmak, T Doran, G Gokmenoglu, ... bioRxiv, 2025.01. 09.632131, 2025 | | 2025 |
Novel CD20+ innate lymphoid cells show increased killing capacity and are related to multiple sclerosis prognosis O Albayrak, T Doran, AB Kizilirmak, M Uzulmez, I Baytekin, K Soylu, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 235-235, 2022 | | 2022 |
The Relationship Between Warfarin Resistance and CYP2C9* 2 and CYP2C9* 3 Variatıons. D Kıraç, AE Yaman, T Doran, EÇ Altunok Medical Journal of Bakirkoy 17 (3), 2021 | | 2021 |
Functional properties of CD56+ CD20 natural killer cells and their relationship with demyelinating disorders O Albayrak, T Doran, A Kizilirmak, M Uzulmez, I Baytekin, K Soylu, ... MULTIPLE SCLEROSIS JOURNAL 27 (2_SUPPL), 2021 | | 2021 |